HK1211867A1 - 聚氧基脂或脂肪酸的眼用製劑和眼病症的治療 - Google Patents

聚氧基脂或脂肪酸的眼用製劑和眼病症的治療

Info

Publication number
HK1211867A1
HK1211867A1 HK15112910.5A HK15112910A HK1211867A1 HK 1211867 A1 HK1211867 A1 HK 1211867A1 HK 15112910 A HK15112910 A HK 15112910A HK 1211867 A1 HK1211867 A1 HK 1211867A1
Authority
HK
Hong Kong
Prior art keywords
polyoxyl
treatment
fatty acid
ophthalmic formulation
ocular conditions
Prior art date
Application number
HK15112910.5A
Other languages
English (en)
Inventor
Ashim K Mitra
Sidney L Weiss
Eugene J Mcnally
Original Assignee
Ocular Technologies Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50148510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1211867(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ocular Technologies Srl filed Critical Ocular Technologies Srl
Publication of HK1211867A1 publication Critical patent/HK1211867A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK15112910.5A 2012-08-24 2015-12-31 聚氧基脂或脂肪酸的眼用製劑和眼病症的治療 HK1211867A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261693189P 2012-08-24 2012-08-24
PCT/US2013/056513 WO2014032026A1 (en) 2012-08-24 2013-08-23 Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions

Publications (1)

Publication Number Publication Date
HK1211867A1 true HK1211867A1 (zh) 2016-06-03

Family

ID=50148510

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112910.5A HK1211867A1 (zh) 2012-08-24 2015-12-31 聚氧基脂或脂肪酸的眼用製劑和眼病症的治療

Country Status (16)

Country Link
US (5) US8980839B2 (zh)
EP (2) EP4218729A1 (zh)
AU (1) AU2013305539B2 (zh)
CA (2) CA2914472C (zh)
DK (1) DK2887923T3 (zh)
ES (1) ES2948387T3 (zh)
FI (1) FI2887923T3 (zh)
HK (1) HK1211867A1 (zh)
HR (1) HRP20230559T1 (zh)
HU (1) HUE062145T2 (zh)
LT (1) LT2887923T (zh)
MX (1) MX361858B (zh)
PL (1) PL2887923T3 (zh)
PT (1) PT2887923T (zh)
SI (1) SI2887923T1 (zh)
WO (1) WO2014032026A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2887923T1 (sl) 2012-08-24 2023-09-29 Sun Pharmaceutical Industries Limited Oftalmična formulacija polioksilnega lipida ali polioksilne maščobne kisline in zdravljenje očesnih stanj
MX2016015211A (es) * 2014-05-23 2017-06-20 Ocular Tech Sarl Formulaciones topicas y usos de las mismas.
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
WO2016028800A1 (en) * 2014-08-20 2016-02-25 A.T. Resolve Sarl Treatment of corneal haze
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
KR101587412B1 (ko) * 2014-10-17 2016-01-21 주식회사 휴온스 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물
US20180133217A1 (en) * 2015-05-04 2018-05-17 Ocular Technologies Sarl Topical formulations and uses thereof
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
FI3373976T3 (fi) * 2015-11-10 2024-03-25 Sun Pharmaceutical Ind Ltd Topikaalisia formulaatioita ja niiden käyttöjä
WO2017083410A1 (en) * 2015-11-12 2017-05-18 Ocular Technologies Sarl Topical formulations and uses thereof
NZ755442A (en) * 2016-02-29 2023-04-28 Sun Pharmaceutical Ind Ltd Topical cyclosporine-containing formulations and uses thereof
WO2017190114A1 (en) 2016-04-29 2017-11-02 i-novion, Inc. Liquid pentablock co-polymer formulations for sustained delivery of therapeutics
HRP20220046T1 (hr) * 2016-11-29 2022-04-15 Oculis SA Priprema čvrstih kompleksa ciklodekstrina za uporabu oftalmološki aktivnih farmaceutskih sastojka
CN107334734B (zh) * 2017-07-10 2020-03-17 浙江大学 一种西罗莫司或其衍生物的眼用制剂
JP2023505409A (ja) * 2019-08-18 2023-02-09 アイビュー セラピューティクス（ズーハイ）カンパニー リミテッド 持続型の眼用薬物送達システムとしてシクロスポリンミセルを含むｉｎ－ｓｉｔｕゲル
CA3161233A1 (en) * 2019-12-09 2021-06-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biomolecule for treatment of corneal pathologies
AU2022295164A1 (en) 2021-06-14 2024-01-25 Sun Pharmaceutical Industries Limited Cyclosporine formulations for use in patients undergoing cataract surgery
IL310823A (en) * 2021-08-20 2024-04-01 Sun Pharmaceutical Ind Ltd Stable cyclosporine ophthalmic formulation and its manufacturing process

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2406A (en) * 1841-12-30 Construction of railroad-scbapers fob cleaning te-ie tracks from sl
FR520E (fr) 1901-11-13 1903-01-26 Bermont Victor Etienne Procédé industriel d'extraction directe du zinc contenu dans les minerais oxydés, et plus spécialement dans la smithsonite (znco3) et la calamine (h2zn2sio5)
ES2098739T3 (es) * 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
US5484597A (en) 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
MX9701946A (es) 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
US6816968B1 (en) * 1998-07-10 2004-11-09 Silverbrook Research Pty Ltd Consumable authentication protocol and system
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CN1951899B (zh) 2000-02-16 2012-02-01 布里格姆及妇女医院股份有限公司 阿司匹林触发的脂质介体
US20030176356A1 (en) 2001-04-24 2003-09-18 University Of North Texas Health Science Center Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma
KR100978836B1 (ko) 2001-10-19 2010-08-30 이소테크니카 인코포레이티드 신규한 시클로스포린 유사체 미세유화액 예비농축물
US7030159B2 (en) 2001-12-18 2006-04-18 The Brigham And Women's Hospital, Inc. Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs
EP1528909A4 (en) 2002-04-01 2006-05-24 Univ Southern California POLYINSATURATED TRIHYDROXYL EICOSANOIDS
US7582785B2 (en) 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
EP3584235A3 (en) 2002-08-12 2020-04-22 Brigham and Women's Hospital Resolvins: biotemplates for novel therapeutic interventions
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
US20040213782A1 (en) 2003-02-03 2004-10-28 Pharmacia Corporation Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure
JP2004238346A (ja) 2003-02-07 2004-08-26 Shiono Chemical Co Ltd トラニラストの安定な水溶液製剤
WO2004078143A2 (en) 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
AU2003228126A1 (en) 2003-05-02 2004-11-23 Arturo Jimenez Bayardo Method of preparing an aqueous solution of cyclosporin-a and resulting aqueous solution
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
EP1755537A4 (en) 2004-04-14 2009-12-09 Univ Boston METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
US20060020563A1 (en) * 2004-07-26 2006-01-26 Coleman Christopher R Supervised neural network for encoding continuous curves
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
CN101102988B (zh) 2004-11-19 2011-12-14 马泰克生物科学公司 来自长链多不饱和脂肪酸的氧脂素及其制备和使用方法
CA2610881A1 (en) * 2005-06-09 2006-12-14 Santen Pharmaceutical Co., Ltd. Eye drop containing roflumilast
CN101198312A (zh) * 2005-06-16 2008-06-11 美瑞德生物工程公司 药物组合物及其用途
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
EP1983977A4 (en) 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
FR2904568B1 (fr) * 2006-08-03 2008-09-05 Dynastar Skis Sa Procede de fabrication d'une planche de glisse
EP2120920A4 (en) 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
US20100310462A1 (en) 2007-04-18 2010-12-09 Biochromix Ab Binding of pathological forms of proteins using conjugated polyelectrolytes
US8512687B2 (en) * 2007-07-09 2013-08-20 Novagali Pharma Sa Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
US20090048929A1 (en) * 2007-08-15 2009-02-19 Paul Im Authenticated travel record
JP5327809B2 (ja) 2007-08-29 2013-10-30 わかもと製薬株式会社 ラタノプロスト含有水性医薬組成物
MX2007011165A (es) 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US8435544B2 (en) 2007-10-08 2013-05-07 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
KR20100107462A (ko) * 2008-01-04 2010-10-05 알콘 파아마슈티칼스 리미티드 안정한 수성 시클로스포린 조성물
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
KR20110010788A (ko) * 2008-05-28 2011-02-07 알콘 리서치, 리미티드 자기보존 에멀젼
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
CN102665685A (zh) * 2009-06-02 2012-09-12 念·吴 纯的peg-脂质缀合物
ES2537385T3 (es) * 2009-06-09 2015-06-08 Aurinia Pharmaceuticals Inc. Sistemas de suministro tópico para uso oftálmico
US20120184552A1 (en) * 2009-09-17 2012-07-19 Senju Pharmaceutical Co., Ltd. Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
WO2011106697A1 (en) 2010-02-25 2011-09-01 Schepens Eye Research Institute Therapeutic compositions for the treatment of dry eye disease
US20130267591A1 (en) 2010-05-07 2013-10-10 Sun Pharma Advanced Research Company Limited Novel ophthalmic compositions
US20130065888A1 (en) 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
KR101211902B1 (ko) 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
MX2014013714A (es) 2012-05-11 2015-08-10 Cipla Ltd Composicion farmaceutica.
SI2887923T1 (sl) 2012-08-24 2023-09-29 Sun Pharmaceutical Industries Limited Oftalmična formulacija polioksilnega lipida ali polioksilne maščobne kisline in zdravljenje očesnih stanj
US10946076B2 (en) 2013-02-13 2021-03-16 The Research Foundation For The State University Of New York Glaucoma treatment
MX2016015211A (es) 2014-05-23 2017-06-20 Ocular Tech Sarl Formulaciones topicas y usos de las mismas.
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US20180133217A1 (en) 2015-05-04 2018-05-17 Ocular Technologies Sarl Topical formulations and uses thereof
FI3373976T3 (fi) 2015-11-10 2024-03-25 Sun Pharmaceutical Ind Ltd Topikaalisia formulaatioita ja niiden käyttöjä
WO2017083410A1 (en) 2015-11-12 2017-05-18 Ocular Technologies Sarl Topical formulations and uses thereof
NZ755442A (en) 2016-02-29 2023-04-28 Sun Pharmaceutical Ind Ltd Topical cyclosporine-containing formulations and uses thereof
WO2017152129A2 (en) 2016-03-03 2017-09-08 Ocular Technologies Sarl Treatment of glaucoma and/or retinal diseases and formulations useful therefore

Also Published As

Publication number Publication date
FI2887923T3 (fi) 2023-06-30
LT2887923T (lt) 2023-07-10
EP2887923B1 (en) 2023-04-05
US8980839B2 (en) 2015-03-17
AU2013305539B2 (en) 2018-08-02
WO2014032026A1 (en) 2014-02-27
EP4218729A1 (en) 2023-08-02
US20160256520A1 (en) 2016-09-08
SI2887923T1 (sl) 2023-09-29
EP2887923A1 (en) 2015-07-01
DK2887923T3 (da) 2023-07-03
US20160256521A1 (en) 2016-09-08
CA2914472C (en) 2019-09-03
PT2887923T (pt) 2023-06-28
US10441630B2 (en) 2019-10-15
US20150165048A1 (en) 2015-06-18
CA2914472A1 (en) 2014-02-27
PL2887923T3 (pl) 2023-08-14
AU2013305539A1 (en) 2015-03-12
EP2887923A4 (en) 2016-03-30
HRP20230559T1 (hr) 2023-09-15
ES2948387T3 (es) 2023-09-11
US20140057854A1 (en) 2014-02-27
HUE062145T2 (hu) 2023-10-28
MX361858B (es) 2018-12-18
US20150148299A1 (en) 2015-05-28
MX2015002239A (es) 2016-01-08
CA3050298A1 (en) 2014-02-27
US9937225B2 (en) 2018-04-10

Similar Documents

Publication Publication Date Title
HK1211867A1 (zh) 聚氧基脂或脂肪酸的眼用製劑和眼病症的治療
HK1213192A1 (zh) 用於在人類受試者中治療眼部疾病的方法和裝置
HK1198631A1 (zh) 眼病症的預防和治療
HK1203478A1 (zh) 用於治療糖尿病性視網膜病及其他眼科疾病的方法
HK1205875A1 (zh) 含有脂肪酸烷基酯、脂肪酸酰胺或甘油三酯脂肪酸酯的含水除草劑濃縮物和使用方法
BR112012032948A2 (pt) dispositivos injectores e método de suprimento de solução oftálmica à córnea do olho
IL236920B (en) Ophthalmic compositions and their use for treatment of eye diseases and disorders in animals
EP2819687A4 (en) COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE
IL235762A0 (en) Stable emulsion to prevent skin irritation and items that use it
IL230957A0 (en) Pharmacy methods and preparations for the treatment of an eye disease in a patient
PL2814463T3 (pl) Okulistyczne kompozycje farmaceutyczne i sposoby ich wytwarzania i stosowania
EP2849749A4 (en) HISTATIN FOR HEALING CORNEAL WOUNDS AND EYE SURFACE DISEASES
EP2906295A4 (en) METHODS OF TREATING OCULAR DISEASES
IL235874A0 (en) Treatment of ocular inflammatory diseases by laquinimod
EP2838509A4 (en) FORMULATIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
IL239078A0 (en) Protein for use in the treatment of eye diseases
EP2844268A4 (en) METHOD FOR THE TREATMENT OF EYE DISEASE AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASE